Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China · Delayed Price · Currency is CNY 19.08
-0.21 (-1.09%)
Jul 25, 2025, 3:04 PM CST
SHE:000623 Revenue
Jilin Aodong Pharmaceutical Group had revenue of 622.62M CNY in the quarter ending March 31, 2025, a decrease of -27.71%. This brings the company's revenue in the last twelve months to 2.37B, down -32.67% year-over-year. In the year 2024, Jilin Aodong Pharmaceutical Group had annual revenue of 2.61B, down -24.31%.
Revenue (ttm)
2.37B
Revenue Growth
-32.67%
P/S Ratio
9.43
Revenue / Employee
412.86K
Employees
5,745
Market Cap
22.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.61B | -838.55M | -24.31% |
| Dec 31, 2023 | 3.45B | 580.91M | 20.25% |
| Jan 1, 2023 | 2.87B | 564.45M | 24.50% |
| Jan 1, 2022 | 2.30B | 52.11M | 2.31% |
| Dec 31, 2020 | 2.25B | -836.73M | -27.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |